Conclusion: Our work reveals that ER stress genes play a crucial role in the BLCA immunological milieu, and HSP90B1 is a potential prognostic biomarker and therapeutic target for cancer immunotherapy. This evidence concerns the gene HSP90B1 and bladder transitional cell carcinoma.